Alembic Pharma gains on USFDA nod for Fluorouracil injection
Alembic Pharmaceuticals rose 3.46% to Rs 518.90 after the pharma company announced that it has received final approval from the US drug regulator for its abbreviated new drug application (ANDA) Fluorouracil injection USP, Pharmacy Bulk Vial.